Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
ANASTROZOLE
VANC PHARMACEUTICALS INC
L02BG03
ANASTROZOLE
1MG
TABLET
ANASTROZOLE 1MG
ORAL
100
Prescription
ANTINEOPLASTIC AGENTS
Active ingredient group (AIG) number: 0128681001; AHFS:
CANCELLED POST MARKET
2019-08-07
Page 1 of 59 PRODUCT MONOGRAPH PR VAN-ANASTROZOLE ANASTROZOLE TABLETS 1 MG Non-Steroidal Aromatase Inhibitor MANUFACTURER AND DISTRIBUTOR: Vanc Pharmaceuticals Inc. Date of Preparation: Building 152, 11782 River Road September 23, 2014 Richmond, BC V6X 1Z7 www.vancpharm.com SUBMISSION CONTROL NUMBER: 177339 Page 2 of 59 TABLE OF CONTENTS TABLE OF CONTENTS ..........................................................................................................2 PART I: HEALTH PROFESSIONAL INFORMATION .......................................................3 SUMMARY PRODUCT INFORMATION......................................................................3 INDICATIONS AND CLINICAL USE ..........................................................................3 CONTRAINDICATIONS..................................................................................................3 WARNINGS AND PRECAUTIONS ...............................................................................4 ADVERSE REACTIONS ..................................................................................................7 DRUG INTERACTIONS..................................................................................................19 DOSAGE AND ADMINISTRATION ............................................................................20 OVERDOSAGE………………………………………………………………………….21 ACTION AND CLINICAL PHARMACOLOGY...........................................................21 STORAGE AND STABILITY .........................................................................................24 SPECIAL HANDLING INSTRUCTIONS.......................................................................24 DOSAGE FORMS, COMPOSITION AND PACKAGING............................................24 PART II: SCIENTIFIC INFORMATION................................................................................25 PHARMACEUTICAL INFORMATION .........................................................................25 CLINI Կարդացեք ամբողջական փաստաթուղթը